29 min listen
Cynata Therapeutics – Producing Stem Cells for Regenerative Medicine
Cynata Therapeutics – Producing Stem Cells for Regenerative Medicine
ratings:
Length:
32 minutes
Released:
Apr 27, 2017
Format:
Podcast episode
Description
Cynata Therapeutics is an Australian stem cell and regenerative medicine company that is creating a therapeutic stem cell platform technology, Cymerus™, using discoveries made at the University of Wisconsin-Madison. Dr Kilian Kelly, Vice President, Cynata talks about Cymerus™. A platform for stem cell technology based upon extremely important and versatile stem cells known as mesenchymoangioblasts (MCAs). MCAs are a predecessor of mesenchymal stem (or stromal) cells (MSCs) which are being examined for such diseases such as osteoarthritis, Crohn’s disease and heart disease. Kilian talks about utilizing iPSCs originating from an adult donor as the preliminary material for producing MCAs and in turn for manufacturing the MSC therapeutic product. This opens up a wide range of therapeutic and manufacturing possibilities for the Company. The Cymerus™ technology has numerous features that makes it perfect for the growth of cell-based therapeutics. This has the potential to create a new standard in the emergent arena of regenerative medicine and stem cell therapeutics and provides Cynata with both a unique differentiator and an important competitive position. Listen, subscribe and share to help our podcasting efforts. Contribute Bitcoin to fuel our interviews and keep us going!
Released:
Apr 27, 2017
Format:
Podcast episode
Titles in the series (100)
Identity Theft Protection Made Easy And Free From Civic.com: Civic.com helps people protect their identity and process immediate alerts through text message if their identity appears to have been compromised. Jonathan Smith, CTO, explains how Civic.com helps empower its users… by Finding Genius Podcast